Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 9, 2026
Causal Prediction of TP53 Variant Pathogenicity Using a Perturbation-Informed Protein Language ModelHuiying Chen, Yang Zhao, Boqiang Hu, et al.
Cancer|May 20, 2026
Integration of venetoclax into a fludarabine and melphalan conditioning regimen in patients aged 50 years and older with acute myeloid leukemia and myelodysplastic syndrome: Results from a phase 2 clinical trialXiaoyu Lai, Panpan Zhu, Luxin Yang, et al.
Haematologica|June 27, 2012
Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignanciesHaowen Xiao, Yi Luo, Xiaoyu Lai, et al.
Plos One|June 12, 2014
The choice of regimens based on bortezomib for patients with newly diagnosed multiple myelomaJingsong He, Li Yang, Xiaoyan Han, et al.
Cancer|June 18, 2025
KRAS mutation status critically determines the clinical outcome of patients with KMT2A-rearranged acute myeloid leukemiaYibo Wu, Xiaolin Yuan, Xiaoyu Lai, et al.
Cell Transplantation|February 12, 2026
Prognostic impact of clinico-genetic characteristics and donor types in NPM1-mutated AML undergoing allogeneic hematopoietic stem cell transplantationXiaolin Yuan, Yibo Wu, Tingting Yang, et al.
Cell Transplantation|January 25, 2024
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic FactorsBingqian Jiang, Yanmin Zhao, Yi Luo, et al.
Annals of Hematology|June 3, 2026
Integrating genomic features for prognosis in Chinese patients with diffuse large B-cell lymphoma following R-CHOP therapyShi Han, Linghui Zhou, Haiqiong Zheng, et al.
Clinical & Translational Immunology|July 4, 2025
Cellular hierarchy for understanding heterogeneity of acute myeloid leukaemia with t(8;21)/RUNX1-RUNX1T1Yibo Wu, Xiaolin Yuan, Xiaoyu Lai, et al.
Biomarker Research|July 7, 2021
Inflammation-related genes S100s, RNASE3, and CYBB and risk of leukemic transformation in patients with myelodysplastic syndrome with myelofibrosisMinghua Hong, Junqing Wu, Lifeng Ma, et al.
Pageof 8